This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Develco Pharma Schweiz Ag. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Innovations by Isabelle Golfier in Opioid Treatment
Introduction
Isabelle Golfier is a notable inventor based in Bantzenheim, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of opioid-induced constipation. With a total of three patents to her name, her work focuses on innovative methods and compositions that enhance patient care.
Latest Patents
One of her latest patents is titled "Method and composition for the treatment of opioid induced constipation." This invention involves a solid oral pharmaceutical dosage form that includes an opioid receptor antagonist. The formulation is designed for twice-daily or once-daily administration, ensuring a steady state of naloxone in the bloodstream. The pharmacokinetics of this formulation are characterized by a rapid first-pass metabolism and a plasma half-life of two hours or less.
Another significant patent is "Naloxone single agent and multilayer tablets." This invention presents a solid oral pharmaceutical composition that releases naloxone in a prolonged manner. The composition is suitable for administration over a period of at least twelve hours, with specific in vitro release rates that ensure effective treatment of opioid-induced constipation.
Career Highlights
Isabelle Golfier has worked with reputable companies in the pharmaceutical industry, including Develco Pharma Schweiz AG and Algobate AG. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout her career, Isabelle has collaborated with professionals such as Hélène Rey and Olaf Mundszinger. These partnerships have likely enriched her research and development efforts, leading to her successful patent applications.
Conclusion
Isabelle Golfier's contributions to the pharmaceutical field, particularly in the treatment of opioid-induced constipation, highlight her innovative spirit and dedication to improving patient outcomes. Her patents reflect a commitment to advancing medical science through effective and practical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile